Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.
- DOI
- 10.3390/v14112315
- Published
- 2022 Oct 22
- Container
- Viruses
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/v14112315,
title = {Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.},
author = {Taramasso L and Falletta A and Ricci E and Orofino G and Squillace N and Menzaghi B and De Socio GV and Molteni C and Pellicanò GF and Gulminetti R and Madeddu G and Sarchi E and Vichi F and Celesia BM and Bonfanti P and Di Biagio A and CISAI Study Group},
year = {2022},
journal = {Viruses},
doi = {10.3390/v14112315},
url = {https://doi.org/10.3390/v14112315}
}RIS
TY - JOUR TI - Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study. AU - Taramasso L AU - Falletta A AU - Ricci E AU - Orofino G AU - Squillace N AU - Menzaghi B AU - De Socio GV AU - Molteni C AU - Pellicanò GF AU - Gulminetti R AU - Madeddu G AU - Sarchi E AU - Vichi F AU - Celesia BM AU - Bonfanti P AU - Di Biagio A AU - CISAI Study Group PY - 2022 JO - Viruses DO - 10.3390/v14112315 UR - https://doi.org/10.3390/v14112315 ER -
APA
L, T., A, F., E, R., G, O., N, S., B, M., GV, D. S., C, M., GF, P., R, G., G, M., E, S., F, V., BM, C., P, B., A, D. B., & Group, C. S. (2022). Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study.. Viruses. https://doi.org/10.3390/v14112315
Source records
- pubmed · retrieved 2026-09-25T17:43:09.659Z